EV
Evotec SE
EVOTF · OTC
$6.69 +0.00% (+$0.00)
Market Cap 1.02B €
P/E Ratio -
Div. Yield -
ROE 26.50%
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/S 1.42x
P/B 1.54x
P/E N/A
Growth
22 /100
Declining Rev. growth 1.60%
Book val. growth 11.84%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 10.48%
Net margin 27.52%
Op. margin 17.69%
Quality
6 /100
Poor ROIC 10.30%
ROE 26.50%
ROA 12.56%
Debt
54 /100
Moderate Debt/Equity 0.71x
Current ratio 2.33x
Int. coverage -10.81x
Stability
45 /100
Moderate Beta 1.26x
Rev. volatility 2.57%
EPS volatility 107.59%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na EVOTF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christian Wojczewski
Employees
4,553
Headquarters
Hamburg
Nadcházející události
05 LIS
Earnings
Upcoming earnings report